Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Response-Guided Therapy with PEG-IFN + NUC in CHB (PYRAMID)
NCT02560649Phase 4Unknown
- Sponsor
- Ruijin Hospital
- Start
- May 2015
- Primary completion
- Aug 2016
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 4 trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02560649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560649.